Skip to main content

Life Sciences

Medical Review In Argus Safety



Much like the Coding Review screen, the Medical Review screen is functionality in Oracle’s Argus Safety that displays the relevant case in a single central window and allows a medical reviewer to see all of the key data points that he or she would use when assessing the case. 


From the Medical Review screen, you can see the narrative in the case, case comments, specific company comments, and the individual event-level assessments.

It’s important to note that this is not just a review window – you can also make modifications to the information on this screen as the medical reviewer.

One of the beautiful things about the Temporal View tab is that you are able to clearly see all of the concomitant therapies, medical history, laboratory dates, suspect medications, and event dates. You can also see a small histogram showing the date and duration of the event and suspect product. This allows you to confirm whether the event was indeed treatment-emergent.


If you checked with a number of your medical reviewers, you may find that they are doing something similar to this on paper when you give them the MedWatch to review, in an attempt to figure out if an event was treatment-emergent. All of this can be done right within Argus Safety.

Additionally, from the Medical Review screen, you can catch and view source files, as well as run any of the many individual case safety reports (ICSR) that come with the system. You can run all of these in draft mode, as it facilitates the ability for some of your medical reviewers, who prefer paper, to still open up a MedWatch report and perform the medical review right there.


In the next post, we’ll highlight how the Argus Safety pharmacovigilance system relates to regulatory report tracking. To read past posts in our Argus Safety features series, click here.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Rodney Lemery

Dr. Rodney Lemery specializes in the implementation, support, and development of software used in the collection, management, and analysis of clinical data. His accomplishments as director of safety and pharmacovigilance at Perficient include the management of numerous clinical application implementation projects. In addition to his expertise in clinical and safety applications, Rodney is able to navigate between the technical and clinical worlds with ease due to his complementary educational background in epidemiology. He also holds a part-time professorship in the School of Health Sciences at Walden University, which solidifies his ability to lead global safety implementations at Perficient. Rodney has been with Perficient, via the acquisition of BioPharm Systems, since 2000. Prior to joining the company, he worked at Pfizer.

More from this Author

Follow Us